This study evaluates the efficacy and applicability of schema therapy for anorexia nervosa.
ID
Source
Brief title
Condition
- Eating disorders and disturbances
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
This study investigates the effects of a thirty week schema therapy in reducing
eating disorder symptoms of patients with anorexia nervosa.
Hypothesis:
Based on previous research (McIntosh et al., 2016; Pauwels, Dierckx,
Schoevaerts, & Claes, 2016; Pugh, 2015; Simpson et al., 2010; Waller, Dickson,
& Ohanian, 2002) it is expected that schema therapy will improve eating
disorder symptoms for patients with anorexia nervosa.
Secondary outcome
This study seeks to examine the changing nature of schema*s and modes in
patients with anorexia nervosa during schema therapy.
Hypothesis: It is expected to demonstrate a reduction in schema*s and modes for
patients with anorexia nervosa during schema therapy.
Background summary
Treatment outcomes in anorexia nervosa are poor and limited evidence is
available in how to treat patients with anorexia nervosa.
Study objective
This study evaluates the efficacy and applicability of schema therapy for
anorexia nervosa.
Study design
A multiple baseline case series design. After a baseline phase of five, six,
seven or eight weeks, fifty weeks of protocoled schema therapy follows. Six
months after therapy is ended, a follow-up measure will be done
Intervention
45 sessions schema therapy (in 50 weeks time)
Study burden and risks
Number of site visits is comparable with treatment as usual, assessment of BMI
is part of the standard procedures at PsyQ, hence not an extra burden
associated with participation. No risks are expected to be associated with
participation in this study. It takes about two and half hours to complete the
questionnaires.
Lijnbaan 4
Den Haag 2512VA
NL
Lijnbaan 4
Den Haag 2512VA
NL
Listed location countries
Age
Inclusion criteria
- A DSM-5 diagnosis anorexia nervosa
- Age between 16-65 years
- BMI >= 15 and somatically stabile as is defined in the department*s crisis
protocol and evaluated by a physician specialised in eating disorders.
Exclusion criteria
- Patients in an acute state of mental crisis who need immediate
hospitalization or treatment for high suicide risk
- Patients with intellectual disability
- Patients who cannot complete the questionnaires because of insufficient
language skills, practical or cognitive limitations
- Not willing (or being able) to sign the informed consent form of this study
Design
Recruitment
metc-ldd@lumc.nl
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL79795.058.23 |